Expression of thymidine phosphorylase and VEGF in esophageal squamous cell carcinoma

Oncology Reports

Volumn 15, Issue 6, 2006, Pages 1497-1501

  Nomiya, Takuma ^a   Nemoto, Kenji ^a   Nakata, Eiko ^a   Takai, Yoshihiro ^a   Yamada, Shogo ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Angiogenesis; Esophageal carcinoma; Microvascular density; Thymidine phosphorylase; VEGF

Indexed keywords

THYMIDINE PHOSPHORYLASE; VASCULOTROPIN A;

AGED; ARTICLE; BIOSYNTHESIS; ENZYMOLOGY; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SQUAMOUS CELL CARCINOMA; VASCULARIZATION;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; THYMIDINE PHOSPHORYLASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34548773784     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.6.1497     Document Type: Article

References (26)

1. Furukawa T, Yoshimura A, Sumizawa T, et al: Angiogenic factor. Nature 356: 668, 1992.
2. Hotchkiss KA, Ashton AW, Klein RS, Lenzi ML, Zhu GH and Schwartz EL: Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res 63: 527-533, 2003. (Pubitemid 36152517)
3. Sumizawa T, Furukawa T, Haraguchi M, et al: Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. Biochem (Tokyo) 114: 9-14, 1993. (Pubitemid 23235624)
4. Moghaddam A and Bicknell R: Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31: 12141-12146, 1992. (Pubitemid 23011359)
5. Finnis C, Dodsworth N, Pollitt CE, Carr G and Sleep D: Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur J Biochem 212: 201-210, 1993. (Pubitemid 23064618)
6. Moghaddam A, Zhang HT, Fan TP, et al: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92: 998-1002, 1995.
7. Ogura O, Kanzaki A, Bando H, Ogura T, Toi M and Takebayashi Y: Expression of thymidylate synthase and thymidine phosphorylase in human breast carcinoma: implication for method to detect expression of these molecules in clinic. Cancer Lett 190: 97-104, 2003. (Pubitemid 36106560)
8. Luccioni C, Beaumatin J, Bardot V and LeFrancois D: Pyrimidine nucleotide metabolism in human colon carcinomas: comparison of normal tissues, primary tumors and xenografts. Int J Cancer 58: 517-522, 1994. (Pubitemid 24268092)
9. Fukuiwa T, Takebayashi Y, Akiba S, et al: Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics. Cancer 85: 960-969, 1999. (Pubitemid 29077575)
10. Takebayashi Y, Yamada K, Miyadera K, et al: The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 32A: 1227-1232, 1996. (Pubitemid 26231808)
11. Takebayashi Y, Miyadera K, Akiyama S, et al: Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 87: 288-295, 1996. (Pubitemid 26117060)
12. Imazano Y, Takebayashi Y, Nishiyama K, et al: Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 15: 2570-2578, 1997. (Pubitemid 27289887)
13. Tsujitani S, Saito H, Maeta Y, et al: Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase. Anticancer Res 24: 1853-1859, 2004. (Pubitemid 38954599)
14. Takebayashi Y, Akiyama S, Akiba S, et al: Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117, 1996. (Pubitemid 26274605)
15. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H and Tominaga T: Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 64: 79-82, 1995.
16. Weidner N: Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors: Breast Cancer Res Treat 36: 169-180, 1995.
17. Nomiya T, Nemoto K, Yamada S, et al: Relationships between radiosensitivity and microvascular density in esophageal carcinoma: significance of hypoxic fraction. Int J Radiat Oncol Biol Phys 58: 589-596, 2004. (Pubitemid 38145594)
18. Takebayashi Y, Natsugoe S, Baba M, et al: Thymidine phosphorylase in human esophageal squamous cell carcinoma. Cancer 85: 282-289, 1999. (Pubitemid 29051280)
19. Morinaga S, Yamamoto Y, Noguchi Y, et al: Platelet-derived endothelial cell growth factor (PD-ECGF) is up-regulated in human hepatocellular carcinoma (HCC) and the corresponding hepatitis liver. Atogastroenterology 50: 1521-1526, 2003. (Pubitemid 37186523)
20. O'Brien TS, Fox SB, Dickinson AJ, et al: Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 56: 4799-4804, 1996. (Pubitemid 26338087)
21. Giatromanolaki A, Koukourakis MI, Comley M, et al: Plateletderived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J Pathol 181: 196-199, 1997. (Pubitemid 27087285)
22. Toi M, Gion M, Biganzoli E, et al: Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications. Angiogenesis 1: 71-83, 1997. (Pubitemid 127505703)
23. Yamaue H, Tanimura H, Kono N, et al: Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer. Anticancer Res 23: 2559-2564, 2003. (Pubitemid 36897128)
24. Ryu SY, Oka K, Tsujii H, Suzuki Y and Nakano T: Platelet-derived endothelial cell growth factor as a prognostic factor for radiotherapy outcome in patients with adenocarcinoma of the uterine cervix. Gynecol Oncol 89: 414-419, 2003. (Pubitemid 36687785)
25. Patterson AV, Zhang H, Moghaddam A, et al: Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′- deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 72: 669-675, 1995.
26. Haraguchi M, Furukawa T, Sumizawa T and Akiyama S: Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res 53: 5680-5682, 1993. (Pubitemid 23360271)